Power Law company profile

Vaxcyte

Biotech & Life Sciences · Foster City, United States · Founded 2013 · IPO 2020 Unicorn

Developing superior and novel vaccines designed to treat some of the most common and deadly infectious diseases

Valuation

$6.82B

Market cap · May/2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

12 investors on Vaxcyte's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 4 investors entered at this stage

Abingworth

Roche Venture Fund

Longitude Capital

CTI Life Sciences

Series B+ 8 investors entered at this stage

TPG Growth

RA Capital Management

Medicxi

Foresite Capital

Janus Henderson Investors

TPG

Pivotal Life Sciences

Frazier Healthcare Partners

Global footprint

Where Vaxcyte has talent and traffic

AI talent share

0.2% of workforce is AI talent
(1 of 527 staff)

Core AI00%

Other AI10.19%

Non-AI workforce52699.81%

Workforce by country

🇺🇸 United States · Foster City HQ

Book a demo for the full country breakdown

Web traffic by country

14K monthly visits
across markets

🇺🇸 United States60%

🇮🇳 India27.9%

🇨🇦 Canada11.4%

🇵🇭 Philippines2.1%

Top 4 markets shown

Patent intelligence

$19M patent portfolio · 18 active families

Estimated portfolio value

$19M

0.28% of market cap · 6.7× smaller than top peer Ambrx ($129M)

18 active patent families

Where Vaxcyte innovates Amino acidMolecular biologyImmunogenicityTGE VACCINEPolysaccharide

Where Vaxcyte concentrates vs peers

Each axis is a top-10 topic across Vaxcyte and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Vaxcyte

An AI-synthesized read of the highest-engagement posts about Vaxcyte on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Vaxcyte on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles